Bookmark

Add to MyYahoo RSS

Salix Pharmaceuticals News

News on Salix Pharmaceuticals (Ticker: SLXP) continually updated from thousands of sources around the net.

Thursday | Investor's Business Daily

Salix Shareholder Alert: Former Sec Attorney Willie Briscoe and...

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Salix Pharmaceuticals, Ltd. concerning the merger with Cosmo Tech, a subsidiary of Cosmo Pharmaceuticals.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Wed Jul 09, 2014

Law.com

Cadwalader Takes Corporate Inversions to Another Level

Several Am Law 100 firms have sought to carve out a niche in the corporate inversions space, but Cadwalader, Wickersham & Taft may have found a way to help more U.S. companies use the controversial maneuver to lower their tax bills.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Cadwalader Wickersham and Taft, Law

Barron's

Salix Pharmaceuticals: - Better Deal Than It Is Being Viewed'

On July 1, Salix Pharmaceuticals jumped 14% after announcing positive results from a drug trial .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Medtronic, Medical Equipment, Pfizer, AstraZeneca Group, Raleigh, NC

Business Journal

The Salix deal boils down to tax savings and drug rights

Adam Derbyshire, Chief Financial Officer and Executive Vice President of Finance & Administration for Salix Pharmaceuticals, says the deal with Cosmo Technologies will bring tax savings.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Barron's

Morning Movers: American Airlines Flies on June Traffic; Celgene Drops on Trial Results

S&P 500 futures have 0.2%, while Dow Jones Industrial Average futures have risen 0.1%.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Financial Markets

Tue Jul 08, 2014

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

DHL and IMG Fashion Celebrate Nicholas K as One of the Winners of First DHL Exported Program in the U.S. )--DHL, the world's leading shipping and logistics provider, and IMG Fashion have announced four winners of this year's inaugural DHL Exported season.

Comment?

Related Topix: Real Estate, Inland Retail Real Estate Trust, August, CA, Food, Agriculture, ADM, Atmos Energy, Energy, Biotech, Medicine, Healthcare Industry

Business Wire

Salix Pharmaceuticals to Combine with Cosmo Technologies to Form Salix Pharmaceuticals, plc

Under the terms of the agreement, Salix will become a wholly-owned subsidiary of Irish domiciled Cosmo Tech, which will change its name to Salix Pharmaceuticals, plc and is expected to have its ordinary shares listed and traded on the NASDAQ Global Select Market.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Inventions, Science / Technology, Marketing

Thu Jul 03, 2014

Investor's Business Daily

Salix, Jazz Lead As Drugmakers Pace IBD 50 For Week

It was a healthy week for leaders, with more than 20% of the IBD 50 list of top-rated growth stocks pressing to new highs.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Mutual Funds, Personal Finance

Investor's Business Daily

Sector Leaders End Mixed; Under Armour Near Buy Point

Sector Leaders gave a mixed showing in Thursday's half-session, even though the market hit fresh milestones.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

MarketWatch

Another good find in specialty pharma

Bill Gunderson is a San Diego money manager, financial talk show host, creator of the Best Stocks Now app and editor of the Gunderson Report .

Comment?

Related Topix: Financial Markets, Biotech, Medicine, Healthcare Industry, Healthcare Law, Law, Raleigh, NC, Gastroenterology

Wed Jul 02, 2014

TheStreet.com

Will This Price Target Increase Help Salix Pharmaceuticals (SLXP) Stock Today?

The firm reiterated its "outperform" rating for the drug manufacturer. The firm raised the price target of the company "to reflect improved visibility on the company's growth drivers," analyst Jason M. Gerberry wrote.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, TheStreet, Financial Markets, Business News

Tue Jul 01, 2014

Benzinga

Morning Market Movers

Transcept Pharmaceuticals rose 32.66% to $2.64 after the company and Paratek Pharmaceuticals signed a merger agreement.

Comment?

Related Topix: Biotech, Transcept Pharmaceuticals, Medicine, Healthcare Industry

The Motley Fool

Why Salix Pharmaceuticals Ltd. Stock Surged

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Irritable Bowel Syndrome, Health

Investor's Business Daily

Salix Pharma's Lead Drug Scores Against Bowel Disease

The Salix press release provided few numbers but said that patients in the phase-three study who took Xifaxan, known generally as rifaximin, for 14 days showed statistically significant improvement in symptoms compared with the placebo group.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Irritable Bowel Syndrome, Health

Investor's Business Daily

Stocks Add To Gains; Salix, Akorn Ramp Higher

The Nasdaq rallied 1.2% to a fresh 14-year high. Meanwhile, the S&P 500 rose 0.7% to a record high.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Financial Markets, Akorn, Irritable Bowel Syndrome, Health

BioSpace

Salix Pharmaceuticals, Ltd. Surges On Encouraging Phase 3 Results For ...

Salix Pharmaceuticals, Ltd. Surges On Encouraging Phase 3 Results For Rifaximin; Stock Up +10.01% At 10:00AM ET On Tuesday Salix Pharmaceuticals, Ltd. Announces Statistically Significant Primary Endpoint Result For TARGET 3 Evaluating The Efficacy And Safety Of Repeat Treatment With Rifaximin 550mg In Subjects With Irritable Bowel Syndrome With ... (more)

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Irritable Bowel Syndrome, Health, Raleigh, NC

The Motley Fool

Tuesday's Top Biotech Stories: CTI BioPharma, Agenus, and Salix Pharmaceuticals

Myelofibrosis, a bone marrow disease which disrupts the production of red blood cells, causes bone marrow scarring, severe anemia, an enlarged spleen and liver, and chronic fatigue.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Marketing, Lymphoma, Health, Crohn's Disease

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

Tolt will now offer manage... )--LiveVox Inc., a leading provider of cloud contact center solutions for enterprise operations, announced that CMO John McNamara will be departing LiveVox to take a po... Salix Announces Statistically Significant Primary Endpoint Result for TARGET 3 Evaluating the Efficacy and Safety of Repeat Treatment with Rifaximin ... (more)

Comment?

Related Topix: Oil & Gas, Chesapeake Energy, Energy, Scottish and Southern Energy, F5 Networks, Biotech, Medicine, Healthcare Industry

Mon Jun 30, 2014

AmericanBankingNews.com

Salix Pharmaceuticals CEO Sells $6,546,173 in Stock

Salix Pharmaceuticals CEO Carolyn J. Logan sold 53,057 shares of the company's stock in a transaction dated Thursday, June 26th.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Wed Jun 25, 2014

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

Staples carr... )--Bruker Corporation today announced that it has received clearance from the China Food and Drug Administration to market and sell its IVD MAL... )--CareCloud, the leading provider of cloud-based practice management, electronic health records , and medical billing software and services, today ann... )--MD Buyline is proud to ... (more)

Comment?

Related Topix: Marketing, Office Equipment, Retail, Staples, Medicine, Fourier Systems, Medical Equipment, D2 Technologies, Healthcare Industry, Bruker Daltonics, Biotech

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••